The Globe and Mail reports in its Friday, March 1, edition that Piper Sandler analyst Charles Neivert has downgraded Nutrien to "underweight" from "neutral." The Globe's David Leeder writes in the Eye On Equities column that Mr. Neivert slashed his share target by $14 to $54 (all figures U.S.). Analysts on average target the shares at $67.71. Mr. Neivert says in a note: "We are downgrading [Nutrien] from 'neutral' based on our belief that planted acreage, yield or both may push the crop carry-out of the soon-to-be planted U.S. corn crop to exceptional volume levels, taking corn prices and thus fertilizer prices downward. A crop of the size we believe possible would also significantly increase U.S. and global stocks-to-use ratios, barring a sizable miss in another major growing region, which would negatively impact nutrient pricing in 1H25 as well. This is not the only risk to grain pricing we see, but it is the most significant and has the most data to support the downside share risk." The Globe reported on June 1, 2022, that Mr. Neivert said the outlook for Nutrien was bright. The shares could then be had for $80. The Globe reported on Feb. 23, 2024, that RBC rated Nutrien "outperform." It was then worth $53.24.